Education
About Us
Working with TipRanks
Follow Us
Transgene SA (FR:TNG)
:TNG
Earnings Data
Report Date
Nov 04, 2025During Market Hours (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
―Last Year’s EPS
-0.16Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call painted a positive picture for Transgene with strong Phase I results for TG4050 and financial stability secured until the end of 2026. However, challenges remain in the broader financing environment, and there is uncertainty about the regulatory pathway for TG4050.Company Guidance
Promising Phase I Results for TG4050
All operable head and neck squamous cell carcinoma patients treated with TG4050 remain disease-free after a median follow-up of 30 months. Safety and immunogenicity endpoints were met, with durable immune responses observed.
Ongoing Progress in Phase II Trial
The Phase II trial for TG4050 in head and neck cancer is progressing well, with plans to randomize the last patient in Q4 2025. First immunogenicity data are expected in the second half of 2026.
Financial Stability Extended
The company's financial outlook has improved, with funding secured until the end of December 2026, thanks to a credit facility and support from TGH.
Strategic Focus on myvac Platform
The company is prioritizing its resources on the myvac platform and TG4050, which is expected to cater to a market of over $1 billion per year at peak.
FR:TNG Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
FR:TNG Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Sep 16, 2025 | €1.16 | €1.10 | -4.76% |
Apr 24, 2025 | €0.60 | €0.61 | +2.00% |
Mar 27, 2025 | €0.66 | €0.67 | +1.05% |
Nov 07, 2024 | €0.92 | €0.94 | +1.95% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Transgene SA (FR:TNG) report earnings?
Transgene SA (FR:TNG) is schdueled to report earning on Nov 04, 2025, During Market Hours (Confirmed).
What is Transgene SA (FR:TNG) earnings time?
Transgene SA (FR:TNG) earnings time is at Nov 04, 2025, During Market Hours (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Transgene SA stock?
The P/E ratio of Transgene is N/A.
What is FR:TNG EPS forecast?
Currently, no data Available